This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Examining the Long-Term Risks of Oophorectomy

Sponsored by Parker, William H., M.D.

About this trial

Last updated 17 years ago

Study ID

PARW-OVCONS-0307

Status

Completed

Type

Observational

Placebo

No

Accepting

18-75 Years
30 to 55 Years
Female
Female

Trial Timing

Ended 21 years ago

What is this trial about?

At the time of hysterectomy for benign disease, the overall health benefits of preserving ovarian function in a large population of women have not been established.

What are the participation requirements?

Yes

Inclusion Criteria

- Women who had hysterectomies were classified into simple hysterectomy or hysterectomy with both ovaries removed.

No

Exclusion Criteria

- Evidence of cancer, coronary heart disease (MI or Angina Pectoris), stroke, or hip fracture before entering the study were excluded. Cancer as an indication for hysterectomy also excluded.

- Women reporting unilateral oophorectomy, unknown oophorectomy status, unknown age of hysterectomy, or those who had oophorectomy before hysterectomy were excluded.